Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Surveillance of Barrettʼs oesophagus
Home
Publications
Surveillance of Barrettʼs oesophagus
Surveillance of Barrettʼs oesophagus
Authors:
JS
Johanna W. van Sandick
Johanna W. van Sandick
JB
Joep F. W. M. Bartelsman
Joep F. W. M. Bartelsman
JL
J. Jan B. van Lanschot
J. Jan B. van Lanschot
GT
Guido N. J. Tytgat
Guido N. J. Tytgat
HO
Hugo Obertop
Hugo Obertop
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
1 January 2000
journal article
research article
Published by
Wolters Kluwer Health
in
European Journal of Gastroenterology & Hepatology
Vol. 12
(1)
,
111, 113-117
DOI:
10.1097/00042737-200012010-00020
Abstract
Background Endoscopic biopsy surveillance of Barrett's oesophagus is generally recommended. However, optimal patient selection and frequency of follow-up are subject to ongoing discussion. Objective To investigate current surveillance practices for Barrett's oesophagus in the Netherlands and to explore their concordance with the guidelines for Barrett's oesophagus surveillance as recommended by the International Society for Diseases of the Esophagus (ISDE). Methods An anonymous questionnaire was mailed to 269 specialist physicians working in the field of gastroenterology. Results The response rate was 88% (238/269). Most of the respondents (84%) performed regular endoscopic follow-up of Barrett's oesophagus. In 52%, endoscopic biopsy sampling corresponded to the ISDE guidelines (four-quadrant biopsies at 2 cm intervals). Agreement was 60% regarding the interval of surveillance for no dysplasia (every 2 years), 52% regarding the interval for low-grade dysplasia (every year) and 54% for management of high-grade dysplasia (oesophagectomy if diagnosis confirmed by a second pathologist or re-biopsy in the short term). When combining these three items, consistency with the ISDE guidelines decreased to 25%. Criteria to select patients for surveillance included age, presence of symptoms, length of Barrett's oesophagus and type of Barrett epithelium. Conclusions The survey indicates widespread practice of cancer surveillance for patients with Barrett's oesophagus in the Netherlands. However, there is limited uniformity in the frequency and intensity of endoscopic histological follow-up. This variability in clinical practice may result from conflicting data and recommendations in the literature. Updated consensus is needed in this area.
Eur J Gastroenterol Hepatol
12:111-117 © 2000 Lippincott Williams & Wilkins European Journal of Gastroenterology & Hepatology 2000, 12:111-117
Keywords
BARRETT\'S OESOPHAGUS
DYSPLASIA
ENDOSCOPIC BIOPSY SURVEILLANCE
METAPLASIA
Related articles
Cited
Cited by 26 articles
Scroll to top